Trusted Science. Delivered the Way You Need.
Visualization & Data Management
See your analyses and predictions come to life with 2D and 3D models, interactive spreadsheets, plots, and more. OpenEye’s visualization tools help you make sense of your data and collaborate with your colleagues.
The shape depiction of the volume of ibuprofen overlaid with the 2D structures of the database molecules. This example shows the the hits sorted by the 3D Shape Tanimoto score.
Trusted Science.
Orion® Web-based Interface
Accessible from your web browser. Perform your visualization, modeling, and analysis from anywhere, anytime, in real-time.
VIDA Desktop Interface
High-quality molecular visualization on Windows, Mac, or Linux. Flexible and fully customizable for your needs with Python scripting.
Delivered the Way You Need.
ROCS X: AI-Enabled Molecular Search Unlocks Trillions
Webinar: OpenEye's Free energy prediction for drug discovery: Ideas at breakfast, discoveries by lunch
Science Brief: Binding Free Energy Redefined: Accurate, Fast, Affordable
Webinar: ML-Enabled integration of affinity prediction and lead discovery: 3D-QSAR
CUP XXV - Santa Fe March 10-12, 2026
Webinar: OpenEye's Free energy prediction for drug discovery: Ideas at breakfast, discoveries by lunch
Science Brief: Binding Free Energy Redefined: Accurate, Fast, Affordable
Webinar: ML-Enabled integration of affinity prediction and lead discovery: 3D-QSAR
CUP XXV - Santa Fe March 10-12, 2026
Resources
Glimpse the Future through News, Events, Webinars and more
News
ROCS X: AI-Enabled Molecular Search Unlocks Trillions
BOSTON, OpenEye miniCUP—Sept. 25, 2025—Cadence Molecular Sciences (OpenEye), a business unit of Cadence (Nasdaq: CDNS), announced today at miniCUP Boston, the launch of ROCS X, an AI-enabled virtual screening solution that allows scientists to conduct 3D searches of trillions of drug-like molecules.
Read now
Webinar
Webinar: OpenEye's Free energy prediction for drug discovery: Ideas at breakfast, discoveries by lunch
Webinar: OpenEye's Free energy prediction for drug discovery: Ideas at breakfast, discoveries by lunch We are continuing our 2025 miniWEBINAR series with our November session led by Chris Neale, Ph.D., who leads the molecular binding affinity solution group at OpenEye, Cadence Molecular Sciences. His expertise and interests include method development for structure-based drug design, cellular signal transduction, and uncertainty quantification. Chris is also an editorial board member at the Biophysical Journal.
Read now